StemRIM

StemRIM Dividend

Dividend of StemRIM (4599.T) as of Nov 5, 2026.

Dividend

0.00JPY

Last updated:

How much dividend does StemRIM 2026 pay?

According to the latest status from November 2026, StemRIM paid a total of 0.00 JPY per share in dividends within the last 12 months. With the current StemRIM price of 123.00 JPY, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Historical StemRIM Dividends

Historical StemRIM Dividends
PaydateDividend

The StemRIM Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2022
0.00 JPY
Jan 1, 2023
0.00 JPY
Jan 1, 2024
0.00 JPY
Jan 1, 2025
0.00 JPY
Jan 1, 2026
0.00 JPY
Jan 1, 2027 (e)
0.00 JPY
Jan 1, 2028 (e)
0.00 JPY
Jan 1, 2029 (e)
0.00 JPY
The StemRIM Dividend history
YEARDividendYoY
est0.00JPY—
est0.00JPY—
est0.00JPY—
0.00JPY—
0.00JPY—
0.00JPY—
0.00JPY—
0.00JPY—
0.00JPY—
0.00JPY—
0.00JPY—
0.00JPY—
0.00JPY—

Is the StemRIM Dividend Safe?

StemRIM has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Dividend Details

Understanding StemRIM's Dividend Distributions

StemRIM’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining StemRIM's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

StemRIM's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in StemRIM’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

StemRIM Stock analysis

What does StemRIM do? StemRIM, Inc. develops and researches regeneration-inducing medicine based on a new action mechanism to promote functional regeneration and healing of damaged biological tissue. The company's main product is stem cell regeneration-inducing medicine, which delivers therapeutic effects similar to regenerative medicine without requiring living cells or tissues. StemRIM's primary customers are medical institutions and healthcare providers seeking advanced treatment options for tissue repair and regeneration. The company generates revenue through the sale of its stem cell regeneration-inducing medicine to these healthcare segments. StemRIM focuses on research and development of medicines that can restore lost function in biological tissue caused by injury or illness. The firm's product line centers around its stem cell regeneration-inducing medicine, which eliminates the need for using living cells in treatment. This innovative approach targets medical professionals and institutions looking for efficient regenerative solutions. StemRIM's business model relies on selling its patented medicine to healthcare providers for clinical applications. The company's revenue streams come from the commercialization of its stem cell regeneration-inducing medicine, which is designed to provide regenerative therapy without cell-based treatments. StemRIM's target market includes hospitals and medical facilities that require advanced regenerative treatments for patients with tissue damage. The firm's research and development efforts are centered on creating medicines that can promote healing through a novel mechanism, differentiating their product from traditional regenerative medicine approaches. StemRIM is one of the most popular companies on Eulerpool.

Frequently Asked Questions about StemRIM stock

StemRIM paid dividends every year for the past 0 years.

StemRIM is assigned to the 'Health' sector.

The dividends of StemRIM are distributed in JPY.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

All Key Metrics — StemRIM